- Published at
- by gurufocus.com
mixed
mixed
RedHill Biopharma Secures Allowance of Key Chinese Patent Application for Proprietary COVID-19 Treatment, RHB-107
PR NewswireRALEIGH, N.C. and TEL-AVIV, Israel, April 28, 2025
Strong Use of Composition-of-Matter Coverage: Patent protects the molecular structure of RHB-